Nuclear HMGB1 protects from nonalcoholic fatty liver disease through negative regulation of liver X receptor

Abstract excerpt

Dysregulations of lipid metabolism in the liver may trigger steatosis progression, leading to potentially severe clinical consequences such as nonalcoholic fatty liver diseases (NAFLDs). Molecular mechanisms underlying liver lipogenesis are very complex and fine-tuned by chromatin dynamics and multiple key transcription factors. Here, we demonstrate that the nuclear factor HMGB1 acts as a strong repressor of...

Topics

Join the communities discussing this publication.

• Cholesterol and Lipid Metabolism
• Drug Transport and Resistance Mechanisms
• Liver Disease Diagnosis and Treatment